Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Oxymetazoline hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for oxymetazoline hydrochloride and what is the scope of oxymetazoline hydrochloride freedom to operate?

Oxymetazoline hydrochloride
is the generic ingredient in four branded drugs marketed by Johnson And Johnson, Allergan Inc, Bayer Healthcare Llc, and St Renatus, and is included in four NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Oxymetazoline hydrochloride has nine patent family members in six countries.

There are three drug master file entries for oxymetazoline hydrochloride. One supplier is listed for this compound.

Summary for Generic Name: oxymetazoline hydrochloride

Drug Master File Entries: see list3
Suppliers / Packagers: see list1
Bulk Api Vendors: see list34
Clinical Trials: see list996
Patent Applications: see list1,415
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:oxymetazoline hydrochloride at DailyMed

Pharmacology for Ingredient: oxymetazoline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Healthcare Llc
oxymetazoline hydrochloride
SOLUTION/DROPS;OPHTHALMIC018471-001May 30, 1986OTCNoNo► Subscribe► Subscribe
St Renatus
oxymetazoline hydrochloride; tetracaine hydrochloride
SPRAY, METERED;NASAL208032-001Jun 29, 2016RXYesYes8,580,282► SubscribeY ► Subscribe
St Renatus
oxymetazoline hydrochloride; tetracaine hydrochloride
SPRAY, METERED;NASAL208032-001Jun 29, 2016RXYesYes6,413,499► Subscribe ► Subscribe
Allergan Inc
oxymetazoline hydrochloride
CREAM;TOPICAL208552-001Jan 18, 2017RXYesYes8,420,688► Subscribe ► Subscribe
St Renatus
oxymetazoline hydrochloride; tetracaine hydrochloride
SPRAY, METERED;NASAL208032-001Jun 29, 2016RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Formulary management
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus